Nevro Corp (NYSE:NVRO)
$ 5.06 -0.26 (-4.89%) Market Cap: 188.65 Mil Enterprise Value: 166.94 Mil PE Ratio: 0 PB Ratio: 0.69 GF Score: 42/100

Nevro Corp Virtual Investor Briefing At 2021 North American Neuromodulation Society (NANS) Virtual Conference Transcript

Jan 16, 2021 / 12:00AM GMT
Operator

Good day, ladies and gentlemen, and welcome to the Nevro 2021 NANS Investor Briefing. (Operator Instructions) Please be advised that today's conference is being recorded. (Operator Instructions) I would now like to turn the call over to Julie Dewey. Please go ahead.

Julie D. Dewey
Nevro Corp. - VP of IR & Corporate Communications

Good day, everyone. This is Julie Dewey, Nevro's Vice President of Investor Relations and Corporate Communications, and I'd like to welcome you to the Nevro 2021 NANS Investor Briefing. Here with me today are Keith Grossman, Nevro's Chairman, CEO and President; Dr. David Caraway, Nevro's Chief Medical Officer; and Rod MacLeod, Nevro's Chief Financial Officer.

Today's presentation slides are posted on our website at nevro.com in the Investors section, and we encourage you to download those slides or view via the webcast. Our speakers will refer to the slide numbers as they present so you can follow along during the presentation.

Moving to Slide 2. I'd like to review the agenda for today. First, Keith will provide

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot